CEL Sci Corp: Form 10-Q/A for the period ended Dec 31, 2019
Filed with the SEC on Dec 30, 2020 and accepted by EDGAR at Dec 30, 2020, 22:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2019-10-01 to 2019-12-31 | $4.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2019-10-01 to 2019-12-31 | −$6.9m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2019-10-01 to 2019-12-31 | −$5.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-10-01 to 2019-12-31 | −$0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-10-01 to 2019-12-31 | −$0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-10-01 to 2019-12-31 | 35,098,608 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2019-10-01 to 2019-12-31 | −$4.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2019-10-01 to 2019-12-31 | $101.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-12-31 | $9.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $10.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $31.5m | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $4.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $22.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2019-12-31 | $9.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001654954-20-014033. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.